NEW YORK (GenomeWeb) – Johns Hopkins University researchers have developed a proof-of-concept platform and assay for use in the clinic to test for the hepatitis C virus. The development comes on the back of an internal study that indicated 60 percent of patients don't return to the clinic to take required confirmatory RNA testing for the hepatitis C virus.

Importantly, the system could enable testing and prescribing treatment for patients during a single office visit, Jeff Tza-Huei Wang, one of the test developers and a researcher at Johns Hopkins, said in an interview.